Women's health is likely to get a boost from investors seeking more diversity in their portfolios. Momentum is building in tandem with the drive to adopt ESG principles in investing, which has led to greater interest in funds related to women's health or in female-founded businesses to meet diversity targets. London-based Life Sciences partner Sophie McGrath spoke on the under-representation of women in business, science, and clinical trials. Read the S&P Global Market Intelligence article here.